Shop
Best Sellers
Tirzepatide (Vial)
Price range: £34.99 through £54.99Tirzepatide
Metabolics & GLP-1 — GIP + GLP-1 Dual Agonist
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and obesity. Clinical trials demonstrate superior weight loss compared to semaglutide, with up to 22.5% mean body weight reduction at 15 mg weekly dosing.
Mechanism
GIP + GLP-1 dual agonist
Half-Life
~5 days
Key Approval
FDA 2022 (Mounjaro®)
Select options
This product has multiple variants. The options may be chosen on the product page
